CBD does not appear to have any psychotropic ("high") effects such as those caused by ∆9-THC in marijuana, but may have anti-anxiety and anti-psychotic effects.[10] As the legal landscape and understanding about the differences in medical cannabinoids unfolds, it will be increasingly important to distinguish "medical marijuana" (with varying degrees of psychotropic effects and deficits in executive function) – from "medical CBD therapies” which would commonly present as having a reduced or non-psychoactive side effect profile.[10][60]
Medical reviews published in 2017 and 2018 incorporating numerous clinical trials concluded that cannabidiol is an effective treatment for certain types of childhood epilepsy.[16][17] An orally administered cannabidiol solution (brand name Epidiolex) was approved by the US Food and Drug Administration in June 2018 as a treatment for two rare forms of childhood epilepsy, Lennox-Gastaut syndrome and Dravet syndrome.[13]
CBD, known scientifically as cannabidiol, is the second most commonly occurring cannabinoid within the marijuana plant, ranking in just below THC, or tetrahydrocannabinol. What is unique and distinctive about CBD, unlike THC this component produces zero psychoactive effects, meaning that it does not create the typical high and euphoria that is linked with marijuana. Furthermore, it has proved to generate immense healing and a multitude of medically beneficial abilities. CBD helps pain on an anatomical level by directly targeting the body’s endocannabinoid system (ECS), which naturally produces some cannabinoids on its own, known as endocannabinoids.

This has been the year medical cannabis hit the mainstream. The government has announced that it is relaxing laws on when cannabis medicines can be prescribed by doctors, following high-profile cases such as that of Billy Caldwell, the 13-year-old boy hospitalised by his epileptic seizures after he was denied legal access to the cannabis oil that helps control them. Meanwhile a new generation of cannabis medicines has shown great promise (both anecdotally and in early clinical trials) in treating a range of ills from anxiety, psychosis and epilepsy to pain, inflammation and acne. And you don’t have to get stoned to reap the health benefits.
The 2016 European Journal of Pain conducted a study on rat models to test the effectiveness of CBD against arthritis in order to see if it could serve as an all-natural alternative to the typical arthritis pain medications, which are often tied with numerous uncomfortable and frustrating side effects. The rats were treated for 4 days with 4 different doses of CBD gel, and the results were quite staggering.
Various studies done on CBD oils and other cannabis products around the world have come to similar conclusions about incorrect label information [24, 53, 54] and the presence of contaminants [54-57]. In the absence of a clear legal status for CBD, or agreement on common safety and quality standards, it may not be surprising that current CBD products leave something to be desired. The time has come for regulators to give CBD the attention it deserves in order to ensure that affordable, safe, and reliable CBD products are available to those who depend on them.
Remember: Do not ingest CBD topicals. They should be used externally only. If your skin symptoms have appeared suddenly or if they are very strong and painful, you should first consult your physician before using any supplements or salves. Don't use salves on open, bleeding wounds. Also, do not apply CBD topicals if you are pregnant, lactating, or suffering from a serious illness.
A lighter concentration of CBD but very convenient to use. You can buy the spray or make your own. Spray it directly in your mouth or even just a mist around you. It’s great for relaxing and stress relief. You can also use for pain by spraying directly on your skin. You can easily take it with you so you have it every day. You can spray a bit on your pulse points for times of stress and anxiety.
A 2017 article published by the National Academies of Sciences, Engineering and Medicine conducted a study in which the results concluded, “In adults with chronic pain, patients who were treated with cannabis or cannabinoids are more likely to experience a clinically significant reduction in pain symptoms.” This statement is quite a massive development for the increasing of tolerance towards CBD and CBD based products.
The dosages mentioned do not take into account the strength of the tincture. I have Elixinol 300, I took 1/2 dropper (0.5ml, which offers 5mg of CBD) as indicated on the bottle and felt severely nauseous for 3 hours thereafter. There is no way I cold take this dose twice per day, as recommended on the bottle. The high dosages on this site must surely be for much weaker concentrations?
A lighter concentration of CBD but very convenient to use. You can buy the spray or make your own. Spray it directly in your mouth or even just a mist around you. It’s great for relaxing and stress relief. You can also use for pain by spraying directly on your skin. You can easily take it with you so you have it every day. You can spray a bit on your pulse points for times of stress and anxiety.

* * This product is not for use by or sale to persons under the age of 18. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult with a physician before use if you have a serious medical condition or use prescription medications. A Doctor’s advice should be sought before using this and any supplemental dietary product. All trademarks and copyrights are property of their respective owners and are not affiliated with nor do they endorse this product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Individual weight loss results will vary. By using this site, you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void Where Prohibited by Law.

Research and regulation of cannabis in general is decades behind other crops and drugs because of its long prohibition. We’re in the early stages of a chaos period that will last a decade at minimum — a substance has to be legal in order for scientists to figure out how it works and for the government to figure out how to ensure it’s safe. Clinical trials take years to complete and will have to build on each other to create a competent understanding. Coupled with modern technology’s ability to disseminate truths, half-truths, and complete lies, this means we’re in a phase ripe for scams, intentional and not.


As mentioned above, cannabis and hemp differ in the levels of naturally occurring THC that they contain.  THC is a cannabinoid like CBD.  However, its properties are very different and often antagonistic to the effects of CBD.  Hemp is naturally high in CBD and low in THC; the reverse is true of cannabis.  In fact, hemp contains only about 0.3% – 1.5% THC, while cannabis contains about 5% – 10% or more THC.
Determining risks and benefits through proper clinical trials remains highly desired, but these will take considerable time and funds. As a result, clinical data will not appear any time soon, while patients will not simply stop using the many CBD products to which they have become accustomed. Taking back regulatory control over CBD could therefore start with a more short-term and achievable approach, i.e., demanding accurate and proper labeling, reflecting in detail what each product does and does not contain, and how it was manufactured. For a clearer judgment of the potential therapeutic effects, the risks, but also the legality of a cannabis extract, it is important to know its exact composition. After all, published data from around the world has taught us that misleading labels as well as harmful contaminants are real and actual problems for CBD products. The analytical methodology and the third-party labs needed for this approach largely already exist, and could easily be optimized to quickly get a better grip on the unrestrained cannabinoid market. This approach would hold each producer strictly accountable for the quality and safety of their own products, as long as there are real legal consequences for those businesses that break the rules. Add to this a system for regular professional audits and inspections, and a crackdown on unsubstantiated health claims, and we have a reasonable system to ensure that CBD can be used responsibly by those who need it, until much needed clinical data become available.
Cannabidiol is currently a class B1 controlled drug in New Zealand under the Misuse of Drugs Act. It is also a prescription medicine under the Medicines Act. In 2017 the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health.

CBD Oil

×